{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:53:21Z","timestamp":1790916801344,"version":"4.1.0"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T00:00:00Z","timestamp":1785369600000},"content-version":"vor","delay-in-days":210,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002703","name":"Jiangsu University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002703","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002863","name":"China Youth Development Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002863","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011493","name":"Taizhou City People's Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011493","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.ctarc.2026.101349","type":"journal-article","created":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:25:26Z","timestamp":1785572726000},"page":"101349","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to clinical intervention"],"prefix":"10.1016","volume":"48","author":[{"given":"Chunmei","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuying","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2209-6678","authenticated-orcid":false,"given":"Jun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0001","first-page":"46","article-title":"Acute myeloid leukemia management and research in 2025","volume":"75","author":"Kantarjian","year":"2025","journal-title":"CA Cancer J. Clin."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101349_bib0002","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ccell.2022.07.002","article-title":"Integrative analysis of drug response and clinical outcome in acute myeloid leukemia","volume":"40","author":"Bottomly","year":"2022","journal-title":"Cancer Cell."},{"issue":"19","key":"10.1016\/j.ctarc.2026.101349_bib0003","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.3390\/cancers13194887","article-title":"Clonal architecture and evolutionary dynamics in acute myeloid leukemias","volume":"13","author":"Duchmann","year":"2021","journal-title":"Cancers. (Basel)"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOH.0000000000000688","article-title":"Clonal hematopoiesis driven by DNMT3A and TET2 mutations: role in monocyte and macrophage biology and atherosclerotic cardiovascular disease","volume":"29","author":"Cobo","year":"2022","journal-title":"Curr. Opin. Hematol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0005","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12935-024-03368-4","article-title":"Comprehensive insights into AML relapse: genetic mutations, clonal evolution, and clinical outcomes","volume":"24","author":"Kim","year":"2024","journal-title":"Cancer Cell. Int."},{"issue":"10","key":"10.1016\/j.ctarc.2026.101349_bib0006","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41408-022-00740-3","article-title":"High efficacy of Azacitidine plus HAG in acute myeloid leukemia: an open-label, single-arm, multi-center, phase 2 study","volume":"12","author":"Li","year":"2022","journal-title":"Blood Cancer J."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0007","doi-asserted-by":"crossref","first-page":"359","DOI":"10.3390\/biomedicines11020359","article-title":"Measurable residual disease and clonal evolution in acute myeloid leukemia from diagnosis to post-transplant follow-up: the role of next-generation sequencing","volume":"11","author":"Sperotto","year":"2023","journal-title":"Biomedicines"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0008","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.1016\/j.cell.2024.04.013","article-title":"Mapping the cellular biogeography of human bone marrow niches using single-cell transcriptomics and proteomic imaging","volume":"187","author":"Bandyopadhyay","year":"2024","journal-title":"Cell"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0009","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1038\/s41588-024-01999-x","article-title":"Single-cell multiomics analysis reveals dynamic clonal evolution and targetable phenotypes in acute myeloid leukemia with complex karyotype","volume":"56","author":"Lepp\u00e4","year":"2024","journal-title":"Nat. Genet."},{"issue":"7834","key":"10.1016\/j.ctarc.2026.101349_bib0010","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41586-020-2864-x","article-title":"Single-cell mutation analysis of clonal evolution in myeloid malignancies","volume":"587","author":"Miles","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0011","doi-asserted-by":"crossref","first-page":"5327","DOI":"10.1038\/s41467-020-19119-8","article-title":"Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics","volume":"11","author":"Morita","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0012","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41467-019-14106-0","article-title":"Clonal competition within complex evolutionary hierarchies shapes AML over time","volume":"11","author":"Sand\u00e9n","year":"2020","journal-title":"Nat. Commun."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.33696\/Signaling.6.133","article-title":"Toward a deeper understanding of clonal evolution in acute myeloid leukemia: translational and clinical impacts","volume":"6","author":"Maher","year":"2025","journal-title":"J. Cell Signal."},{"key":"10.1016\/j.ctarc.2026.101349_bib0014","doi-asserted-by":"crossref","unstructured":"Chow RD, Velu P, Deihimi S, et al. Early drivers of clonal hematopoiesis shape the evolutionary trajectories of de novo acute myeloid leukemia. medRxiv. 2024.","DOI":"10.1101\/2024.08.31.24312756"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101349_bib0015","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/s41375-024-02211-z","article-title":"Mutation order in acute myeloid leukemia identifies uncommon patterns of evolution and illuminates phenotypic heterogeneity","volume":"38","author":"Schwede","year":"2024","journal-title":"Leukemia"},{"issue":"02","key":"10.1016\/j.ctarc.2026.101349_bib0016","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/BS9.0000000000000042","article-title":"Preleukemic stem cells: leave it or not?","volume":"2","author":"Su","year":"2020","journal-title":"Blood Sci."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101349_bib0017","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3892\/ol.2025.14970","article-title":"Coexistence of acute myeloid leukemia with a complex chromosomal translocation and monoclonal gammopathy of undetermined significance: a case report and literature review","volume":"29","author":"Qiao","year":"2025","journal-title":"Oncol. Lett."},{"issue":"04","key":"10.1016\/j.ctarc.2026.101349_bib0018","doi-asserted-by":"crossref","DOI":"10.1097\/BS9.0000000000000267","article-title":"FLT3-ITD with NPM1 and\/or DNMT3A co-mutations in acute myeloid leukemia: prognostic significance and the role of maintenance therapy post-transplantation","volume":"7","author":"Li","year":"2025","journal-title":"Blood Sci."},{"issue":"7488","key":"10.1016\/j.ctarc.2026.101349_bib0019","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/nature13038","article-title":"Identification of pre-leukaemic haematopoietic stem cells in acute leukaemia","volume":"506","author":"Shlush","year":"2014","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101349_bib0020","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/nm.4410","article-title":"Clonal evolution in leukemia","volume":"23","author":"Ferrando","year":"2017","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101349_bib0021","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1182\/bloodadvances.2024015149","article-title":"Persistent postremission clonal hematopoiesis shapes the relapse trajectories of acute myeloid leukemia","volume":"9","author":"Chow","year":"2025","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0022","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230931","article-title":"Genetic and environmental risks for clonal hematopoiesis and cancer","volume":"222","author":"Franco","year":"2025","journal-title":"J. Exp. Med."},{"issue":"26","key":"10.1016\/j.ctarc.2026.101349_bib0023","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1182\/blood.2023022222","article-title":"Causes and consequences of clonal hematopoiesis","volume":"142","author":"Weeks","year":"2023","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0024","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.cell.2012.06.023","article-title":"The origin and evolution of mutations in acute myeloid leukemia","volume":"150","author":"Welch","year":"2012","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0025","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1158\/2643-3230.BCD-24-0235","article-title":"The crossroads of clonal evolution, differentiation hierarchy, and ontogeny in leukemia development","volume":"6","author":"Sturgeon","year":"2025","journal-title":"Blood Cancer Disc."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101349_bib0026","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.leu.2403670","article-title":"Animal models of acute myelogenous leukaemia \u2013 development, application and future perspectives","volume":"19","author":"Mc Cormack","year":"2005","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101349_bib0027","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.3390\/cancers14092182","article-title":"Dissecting the genetic and non-genetic heterogeneity of acute myeloid leukemia using next-generation sequencing and in vivo models","volume":"14","author":"Desai","year":"2022","journal-title":"Cancers. (Basel)"},{"issue":"16","key":"10.1016\/j.ctarc.2026.101349_bib0028","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.3390\/cells13161392","article-title":"Common driver mutations in AML: biological impact, clinical considerations, and treatment strategies","volume":"13","author":"Nong","year":"2024","journal-title":"Cells"},{"issue":"18","key":"10.1016\/j.ctarc.2026.101349_bib0029","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1182\/blood.2025029691","article-title":"A clinical guide to TP53 mutations in myeloid neoplasms","volume":"146","author":"Urrutia","year":"2025","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0030","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s41232-023-00267-5","article-title":"Cellular niches for hematopoietic stem cells in bone marrow under normal and malignant conditions","volume":"43","author":"Omatsu","year":"2023","journal-title":"Inflamm. Regen."},{"key":"10.1016\/j.ctarc.2026.101349_bib0031","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1016\/j.csbj.2023.08.008","article-title":"Translation of biophysical environment in bone into dynamic cell culture under flow for bone tissue engineering","volume":"21","author":"Yamada","year":"2023","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ctarc.2026.101349_bib0032","first-page":"1","article-title":"Is the bone marrow microenvironment the hidden catalyst in malignant haematopoiesis?","author":"Mian","year":"2025","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101349_bib0033","doi-asserted-by":"crossref","first-page":"63","DOI":"10.21037\/atm-23-1824","article-title":"Remodeling of the bone marrow microenvironment during acute myeloid leukemia progression","volume":"12","author":"Urs","year":"2024","journal-title":"Ann. Transl. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0034","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/s41420-022-01193-0","article-title":"The genesis and evolution of acute myeloid leukemia stem cells in the microenvironment: from biology to therapeutic targeting","volume":"8","author":"Chen","year":"2022","journal-title":"Cell Death. Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0035","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1182\/hematology.2019000045","article-title":"Inflammatory bone marrow microenvironment","volume":"2019","author":"Leimk\u00fchler","year":"2019","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101349_bib0036","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1182\/blood-2017-12-784132","article-title":"The interplay of leukemia cells and the bone marrow microenvironment","volume":"131","author":"Duarte","year":"2018","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0037","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s13287-021-02444-0","article-title":"Bone marrow-derived mesenchymal stem\/stromal cells in patients with acute myeloid leukemia reveal transcriptome alterations and deficiency in cellular vitality","volume":"12","author":"Zhang","year":"2021","journal-title":"Stem Cell Res. Ther."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0038","article-title":"Construction of a prognostic risk model for acute myeloid leukemia based on exosomal genes and analysis of immune microenvironment characteristics","volume":"15","author":"Wang","year":"2025","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0039","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-021-00233-2","article-title":"Leukemia stem cell\u2013bone marrow microenvironment interplay in acute myeloid leukemia development","volume":"10","author":"Yao","year":"2021","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.ctarc.2026.101349_bib0040","doi-asserted-by":"crossref","DOI":"10.3389\/frhem.2024.1334807","article-title":"Exploring the intricate cross-talk between clonal expansion and the bone marrow niche","volume":"3","author":"Ngo","year":"2024","journal-title":"Front Hematol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0041","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/s41375-021-01350-x","article-title":"Catch me if you can: how AML and its niche escape immunotherapy","volume":"36","author":"Tettamanti","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.ctarc.2026.101349_bib0042","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.3389\/fimmu.2020.01710","article-title":"PD-L1 is expressed and promotes the expansion of regulatory T cells in acute myeloid leukemia","volume":"11","author":"Dong","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101349_bib0043","article-title":"Immunosuppressive cells in acute myeloid leukemia: mechanisms and therapeutic target","volume":"16","author":"Liu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ctarc.2026.101349_bib0044","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1049301","article-title":"Regulation of hematopoietic and leukemia stem cells by regulatory T cells","volume":"13","author":"Riether","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0045","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1038\/s41467-023-43697-y","article-title":"Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells","volume":"14","author":"McClatchy","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101349_bib0046","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.exphem.2020.01.011","article-title":"Clonal hematopoiesis and inflammation: partners in leukemogenesis and comorbidity","volume":"83","author":"Cook","year":"2020","journal-title":"Exp. Hematol."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0047","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1053\/j.seminhematol.2024.01.013","article-title":"TET2 mutation as prototypic clonal hematopoiesis lesion","volume":"61","author":"Guarnera","year":"2024","journal-title":"Semin. Hematol."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0048","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/nm.3733","article-title":"Age-related mutations associated with clonal hematopoietic expansion and malignancies","volume":"20","author":"Xie","year":"2014","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.ctarc.2026.101349_bib0049","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1073\/pnas.1324297111","article-title":"Preleukemic mutations in human acute myeloid leukemia affect epigenetic regulators and persist in remission","volume":"111","author":"Corces-Zimmerman","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101349_bib0050","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1182\/blood.2024024310","article-title":"Molecular, clinical, and therapeutic determinants of outcome in NPM1-mutated AML","volume":"144","author":"Othman","year":"2024","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101349_bib0051","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.3390\/biomedicines11071805","article-title":"Genetic, phenotypic, and clinical heterogeneity of NPM1-mutant acute myeloid leukemias","volume":"11","author":"Testa","year":"2023","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0052","doi-asserted-by":"crossref","first-page":"7244","DOI":"10.1038\/s41467-021-27472-5","article-title":"Clonal architecture predicts clinical outcomes and drug sensitivity in acute myeloid leukemia","volume":"12","author":"Benard","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101349_bib0053","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.stem.2025.04.012","article-title":"Deconvoluting clonal and cellular architecture in IDH-mutant acute myeloid leukemia","volume":"32","author":"Sirenko","year":"2025","journal-title":"Cell. Stem. Cell."},{"issue":"7913","key":"10.1016\/j.ctarc.2026.101349_bib0054","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41586-022-04785-z","article-title":"The longitudinal dynamics and natural history of clonal haematopoiesis","volume":"606","author":"Fabre","year":"2022","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0055","doi-asserted-by":"crossref","first-page":"4666","DOI":"10.1038\/s41467-024-48617-2","article-title":"A theory of evolutionary dynamics on any complex population structure reveals stem cell niche architecture as a spatial suppressor of selection","volume":"15","author":"Kuo","year":"2024","journal-title":"Nat. Commun."},{"issue":"7382","key":"10.1016\/j.ctarc.2026.101349_bib0056","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature10738","article-title":"Clonal evolution in relapsed acute myeloid leukaemia revealed by whole-genome sequencing","volume":"481","author":"Ding","year":"2012","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0057","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1002\/gcc.22806","article-title":"Clonal evolution of acute myeloid leukemia from diagnosis to relapse","volume":"58","author":"Vosberg","year":"2019","journal-title":"Genes Chromosomes Cancer"},{"issue":"9","key":"10.1016\/j.ctarc.2026.101349_bib0058","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1038\/s41375-022-01650-w","article-title":"Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603\/RATIFY trial","volume":"36","author":"Jahn","year":"2022","journal-title":"Leukemia"},{"issue":"16","key":"10.1016\/j.ctarc.2026.101349_bib0059","doi-asserted-by":"crossref","first-page":"4671","DOI":"10.1182\/bloodadvances.2023010482","article-title":"Framework of clonal mutations concurrent with WT1 mutations in adults with acute myeloid leukemia: alliance for Clinical Trials in Oncology study","volume":"7","author":"Bhatnagar","year":"2023","journal-title":"Blood Adv."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101349_bib0060","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/nrc3063","article-title":"Human cancers express mutator phenotypes: origin, consequences and targeting","volume":"11","author":"Loeb","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ctarc.2026.101349_bib0061","unstructured":"Watson C. The evolutionary dynamics of clonal haematopoiesis and its progression to acute myeloid leukaemia. [PhD thesis]. 2022."},{"key":"10.1016\/j.ctarc.2026.101349_bib0062","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1421816","article-title":"Therapeutic targeting of PARP with immunotherapy in acute myeloid leukemia","volume":"15","author":"Bian","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0063","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1080\/16078454.2022.2107970","article-title":"The signature based on seven genomic instability-related genes could predict the prognosis of acute myeloid leukemia patients","volume":"27","author":"Nie","year":"2022","journal-title":"Hematology"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0064","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/s41420-023-01528-5","article-title":"NADPH oxidase mediated oxidative stress signaling in FLT3-ITD acute myeloid leukemia","volume":"9","author":"Chen","year":"2023","journal-title":"Cell Death. Discov."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0065","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.3390\/biomedicines13123007","article-title":"Pandora\u2019s box of AML: how TP53 mutations defy therapy and hint at new hope","volume":"13","author":"Olesinski","year":"2025","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0066","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/s41408-024-01186-5","article-title":"What have we learned about TP53-mutated acute myeloid leukemia?","volume":"14","author":"Shahzad","year":"2024","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ctarc.2026.101349_bib0067","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/ajh.27655","article-title":"TP53 mutated myeloid neoplasms: 2024 update on diagnosis, risk stratification, and management","volume":"100","author":"Shah","year":"2025","journal-title":"Am. J. Hematol."},{"key":"10.1016\/j.ctarc.2026.101349_bib0068","article-title":"Human TET2-mutant clonal hematopoiesis expansion is driven by distinct inflammatory signaling responses in stem cells versus myeloid progeny","author":"Encabo","year":"2025","journal-title":"Blood Cancer Discov."},{"key":"10.1016\/j.ctarc.2026.101349_bib0069","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.exphem.2019.12.005","article-title":"Environmental influences on clonal hematopoiesis","volume":"83","author":"King","year":"2020","journal-title":"Exp. Hematol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101349_bib0070","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/2159-8290.CD-18-1453","article-title":"Clonal selection with RAS pathway activation mediates secondary clinical resistance to selective FLT3 inhibition in acute myeloid leukemia","volume":"9","author":"McMahon","year":"2019","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0071","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12943-025-02323-9","article-title":"Drug-induced tolerant persisters in tumor: mechanism, vulnerability and perspective implication for clinical treatment","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0072","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1038\/s41467-017-01968-5","article-title":"Integrating evolutionary dynamics into treatment of metastatic castrate-resistant prostate cancer","volume":"8","author":"Zhang","year":"2017","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101349_bib0073","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1158\/0008-5472.CAN-17-2649","article-title":"Spatial heterogeneity and evolutionary dynamics modulate time to recurrence in continuous and adaptive cancer therapies","volume":"78","author":"Gallaher","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ctarc.2026.101349_bib0074","article-title":"Combination therapy involving azacitidine for acute myeloid leukemia patients ineligible for intensive chemotherapy","author":"Li","year":"2024","journal-title":"Leuk. Res."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101349_bib0075","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/ng.3489","article-title":"Identification of neutral tumor evolution across cancer types","volume":"48","author":"Williams","year":"2016","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101349_bib0076","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1038\/s41588-020-0675-5","article-title":"Subclonal reconstruction of tumors by using machine learning and population genetics","volume":"52","author":"Caravagna","year":"2020","journal-title":"Nat. Genet."},{"issue":"6","key":"10.1016\/j.ctarc.2026.101349_bib0077","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1182\/blood-2017-02-769869","article-title":"Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly","volume":"130","author":"Zink","year":"2017","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101349_bib0078","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s41375-020-0932-8","article-title":"Clonal dominance is an adverse prognostic factor in acute myeloid leukemia treated with intensive chemotherapy","volume":"35","author":"Cerrano","year":"2021","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101349_bib0079","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2208176120","article-title":"Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells","volume":"120","author":"Fortin","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0080","doi-asserted-by":"crossref","first-page":"85","DOI":"10.51803\/yssr.1525146","article-title":"Evolutionary game theory: a general review","volume":"10","author":"Yolusever","year":"2024","journal-title":"Yildiz Soc. Sci. Rev."},{"issue":"2","key":"10.1016\/j.ctarc.2026.101349_bib0081","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s13235-021-00397-w","article-title":"The contribution of evolutionary game theory to understanding and treating cancer","volume":"12","author":"W\u00f6lfl","year":"2022","journal-title":"Dyn. Games. Appl."},{"key":"10.1016\/j.ctarc.2026.101349_bib0082","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-026-02734-1","article-title":"Decoding the archipelago: single-cell biomarkers rechart the molecular geography of acute myeloid leukemia","volume":"24","author":"Kang","year":"2026","journal-title":"Cell Commun. Signal."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0083","article-title":"Deciphering cell states and the cellular ecosystem to improve risk stratification in acute myeloid leukemia","volume":"26","author":"Zhang","year":"2024","journal-title":"Br. Bioinform"},{"issue":"5","key":"10.1016\/j.ctarc.2026.101349_bib0084","doi-asserted-by":"crossref","first-page":"371","DOI":"10.3390\/children8050371","article-title":"Far from health: the bone marrow microenvironment in AML, a leukemia supportive shelter","volume":"8","author":"Sendker","year":"2021","journal-title":"Children"},{"key":"10.1016\/j.ctarc.2026.101349_bib0085","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.75908","article-title":"Crosstalk between AML and stromal cells triggers acetate secretion through the metabolic rewiring of stromal cells","volume":"11","author":"Vilaplana-Lopera","year":"2022","journal-title":"Elife"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101349_bib0086","first-page":"831","article-title":"Reciprocal interactions of leukemic cells with bone marrow stromal cells promote enrichment of leukemic stem cell compartments in response to curcumin and daunorubicin","volume":"18","author":"Mohammadi","year":"2017","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"3","key":"10.1016\/j.ctarc.2026.101349_bib0087","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1013897","article-title":"Inverse game theory characterizes frequency-dependent selection driven by karyotypic diversity in triple-negative breast cancer","volume":"22","author":"Veith","year":"2026","journal-title":"PLoS. Comput. Biol."},{"key":"10.1016\/j.ctarc.2026.101349_bib0088","doi-asserted-by":"crossref","unstructured":"Barker-Clarke RJ, Pachter JA, Gray JM, et al. Hidden interactions: frequency-dependence emulates selection-driven dynamics in evolving populations. bioRxiv. 2023:2023.03.15.532871.","DOI":"10.1101\/2023.03.15.532871"},{"issue":"6485","key":"10.1016\/j.ctarc.2026.101349_bib0089","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1126\/science.aay9333","article-title":"The evolutionary dynamics and fitness landscape of clonal hematopoiesis","volume":"367","author":"Watson","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101349_bib0090","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1158\/2159-8290.CD-24-0861","article-title":"The hallmarks of cancer as eco-evolutionary processes","volume":"15","author":"Bhattacharya","year":"2025","journal-title":"Cancer Discov."},{"issue":"9","key":"10.1016\/j.ctarc.2026.101349_bib0091","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s11128-025-04913-4","article-title":"Mapping the frontier: a review of quantum and evolutionary game theory for complex decision-making","volume":"24","author":"Sanz-Mart\u00edn","year":"2025","journal-title":"Quantum. Inf. Process."},{"key":"10.1016\/j.ctarc.2026.101349_bib0092","doi-asserted-by":"crossref","DOI":"10.1016\/j.chaos.2024.115970","article-title":"Noise-induced stochastic Nash equilibrium in evolutionary game dynamics","volume":"192","author":"Li","year":"2025","journal-title":"Chaos Solit. Fractals"},{"issue":"193","key":"10.1016\/j.ctarc.2026.101349_bib0093","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2022.0346","article-title":"The role of evolutionary game theory in spatial and non-spatial models of the survival of cooperation in cancer: a review","volume":"19","author":"Coggan","year":"2022","journal-title":"J. R. Soc. Interface"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101349_bib0094","doi-asserted-by":"crossref","first-page":"979","DOI":"10.2217\/fon-2017-0523","article-title":"The role of IDH mutations in acute myeloid leukemia","volume":"14","author":"Montalban-Bravo","year":"2018","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.ctarc.2026.101349_bib0095","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1038\/leu.2016.71","article-title":"Enantiomer-specific and paracrine leukemogenicity of mutant IDH metabolite 2-hydroxyglutarate","volume":"30","author":"Chaturvedi","year":"2016","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ctarc.2026.101349_bib0096","article-title":"Potent immunosuppressive effects of the oncometabolite R-2-hydroxyglutarate","volume":"7","author":"Galluzzi","year":"2018","journal-title":"Oncoimmunology"},{"issue":"13","key":"10.1016\/j.ctarc.2026.101349_bib0097","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1016\/j.celrep.2017.03.018","article-title":"Identification of interleukin-1 by functional screening as a key mediator of cellular expansion and disease progression in acute myeloid leukemia","volume":"18","author":"Carey","year":"2017","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0098","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1038\/leu.2015.163","article-title":"Coordinate regulation of residual bone marrow function by paracrine trafficking of AML exosomes","volume":"29","author":"Huan","year":"2015","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.ctarc.2026.101349_bib0099","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1516192","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"Papaemmanuil","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ctarc.2026.101349_bib0100","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1182\/bloodadvances.2019001181","article-title":"Single-cell mutational profiling enhances the clinical evaluation of AML MRD","volume":"4","author":"Ediriwickrema","year":"2020","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0101","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41408-025-01287-9","article-title":"Genomic and transcriptomic determinants of clinical outcomes in patients with AML and DNMT3A mutations","volume":"15","author":"Ni","year":"2025","journal-title":"Blood Cancer J."},{"issue":"12","key":"10.1016\/j.ctarc.2026.101349_bib0102","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1182\/blood.2022016867","article-title":"Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN","volume":"140","author":"D\u00f6hner","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.ctarc.2026.101349_bib0103","first-page":"1","article-title":"The impact of DNMT3A mutation on survival of AML patients receiving allotransplant in first remission depends on the karyotype and co-occurring mutations","author":"Abou Dalle","year":"2025","journal-title":"Bone Marrow Transpl."},{"key":"10.1016\/j.ctarc.2026.101349_bib0104","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.93019","article-title":"Convergent epigenetic evolution drives relapse in acute myeloid leukemia","volume":"13","author":"Nuno","year":"2024","journal-title":"Elife"},{"issue":"7","key":"10.1016\/j.ctarc.2026.101349_bib0105","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/nm.4125","article-title":"Distinct evolution and dynamics of epigenetic and genetic heterogeneity in acute myeloid leukemia","volume":"22","author":"Li","year":"2016","journal-title":"Nat. Med."},{"issue":"14","key":"10.1016\/j.ctarc.2026.101349_bib0106","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.3390\/cells12141849","article-title":"Mathematical modeling of clonal interference by density-dependent selection in heterogeneous cancer cell lines","volume":"12","author":"Veith","year":"2023","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ctarc.2026.101349_bib0107","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1038\/s41591-018-0201-9","article-title":"Induction of resistance to chimeric antigen receptor T cell therapy by transduction of a single leukemic B cell","volume":"24","author":"Ruella","year":"2018","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.ctarc.2026.101349_bib0108","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1038\/s41467-020-15596-z","article-title":"Exploiting evolutionary steering to induce collateral drug sensitivity in cancer","volume":"11","author":"Acar","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ctarc.2026.101349_bib0109","first-page":"30","article-title":"S129: takeAim Leukemia \u2013 a phase 1\/2a study of the IRAK4 inhibitor emavusertib (CA-4948) as monotherapy or in combination with azacitidine or venetoclax in relapsed\/refractory AML or MDS","volume":"6","author":"Garcia-Manero","year":"2022","journal-title":"Hema Sphere"},{"issue":"3","key":"10.1016\/j.ctarc.2026.101349_bib0110","doi-asserted-by":"crossref","DOI":"10.1038\/bcj.2017.21","article-title":"A phase 1\/2 study of chemosensitization with plerixafor plus G-CSF in relapsed or refractory acute myeloid leukemia","volume":"7","author":"Uy","year":"2017","journal-title":"Blood Cancer J."},{"key":"10.1016\/j.ctarc.2026.101349_bib0111","first-page":"1","article-title":"Exploring the bone marrow microenvironment as a therapeutic barrier and targetable source of crosstalk in acute myeloid leukemia","volume":"16","author":"Kolosova","year":"2026","journal-title":"Blood Lymphat. Cancer"}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294226002601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T03:56:40Z","timestamp":1790913400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294226002601"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":111,"alternative-id":["S2468294226002601"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101349","relation":{},"ISSN":["2468-2942"],"issn-type":[{"value":"2468-2942","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The eco-evolutionary dynamics of acute myeloid leukemia: From clonal games to clinical intervention","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2026.101349","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101349"}}